NO20040987L - Biologiske produkter - Google Patents

Biologiske produkter

Info

Publication number: NO20040987L
Authority: NO; Norway
Prior art keywords: disclosed; cdr; antibody; antibody molecules; biological products
Prior art date: 2001-10-10

Application number

NO20040987A

Other languages

English (en)

Norwegian (no)

Inventor

Andrew George Popplewell

Simon Peter Tickle

Karen Zinkewich-Peotti

Robert Kendall Morrison

Original Assignee

Celltech R&D Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-10

Filing date

2004-03-08

Publication date

2004-05-10

2004-03-08 Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd

2004-05-10 Publication of NO20040987L publication Critical patent/NO20040987L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Cell Biology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Zoology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Jellies, Jams, And Syrups (AREA)
Bakery Products And Manufacturing Methods Therefor (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)

NO20040987A 2001-10-10 2004-03-08 Biologiske produkter NO20040987L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0124317.9A GB0124317D0 (en)	2001-10-10	2001-10-10	Biological products
PCT/GB2002/004619 WO2003031475A2 (en)	2001-10-10	2002-10-10	Antibodies against kdr, their production and uses

Publications (1)

Publication Number	Publication Date
NO20040987L true NO20040987L (no)	2004-05-10

Family

ID=9923562

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20040987A NO20040987L (no)	2001-10-10	2004-03-08	Biologiske produkter

Country Status (24)

Country	Link
US (2)	US7452976B2 (da)
EP (1)	EP1438340B1 (da)
JP (2)	JP4323312B2 (da)
KR (2)	KR101018908B1 (da)
CN (1)	CN1568331A (da)
AT (1)	ATE482234T1 (da)
AU (1)	AU2002334135B8 (da)
BR (1)	BR0212756A (da)
CA (1)	CA2458464A1 (da)
CO (1)	CO5580838A2 (da)
DE (1)	DE60237778D1 (da)
DK (1)	DK1438340T3 (da)
EA (1)	EA010970B1 (da)
ES (1)	ES2351208T3 (da)
GB (1)	GB0124317D0 (da)
HU (1)	HUP0401618A3 (da)
IL (1)	IL160849A0 (da)
IS (1)	IS7173A (da)
MX (1)	MXPA04003274A (da)
NO (1)	NO20040987L (da)
NZ (1)	NZ532758A (da)
PL (1)	PL208848B1 (da)
WO (1)	WO2003031475A2 (da)
ZA (1)	ZA200401910B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0129105D0 (en) *	2001-12-05	2002-01-23	Celltech R&D Ltd	Expression control using variable intergenic sequences
DE10303974A1 (de)	2003-01-31	2004-08-05	Abbott Gmbh & Co. Kg	Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
UY28424A1 (es)	2003-07-22	2005-02-28	Schering Ag	Anticuerpos rgi y usos de los mismos.
GB0329825D0 (en) *	2003-12-23	2004-01-28	Celltech R&D Ltd	Biological products
JP5102028B2 (ja)	2004-07-26	2012-12-19	バイオジェン・アイデック・エムエイ・インコーポレイテッド	抗ｃｄ１５４抗体
US7785591B2 (en)	2004-10-14	2010-08-31	Morphosys Ag	Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies
EP2339001A2 (en) *	2005-03-25	2011-06-29	National Research Council of Canada	Method for isolation of soluble polypeptides
GB0520169D0 (en) *	2005-10-04	2005-11-09	Celltech R&D Ltd	Biological products
RU2442793C2 (ru)	2005-11-30	2012-02-20	Эбботт Лэборетриз	АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
CN101506236B (zh)	2005-11-30	2012-12-12	雅培制药有限公司	抗淀粉样β蛋白的单克隆抗体及其用途
DOP2006000277A (es)	2005-12-12	2007-08-31	Bayer Pharmaceuticals Corp	Anticuerpos anti mn y métodos para su utilización
TWI551607B (zh)	2006-07-14	2016-10-01	Ａｃ免疫公司	人類化抗體
US8455626B2 (en)	2006-11-30	2013-06-04	Abbott Laboratories	Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2124952A2 (en)	2007-02-27	2009-12-02	Abbott GmbH & Co. KG	Method for the treatment of amyloidoses
EP2125894B1 (en)	2007-03-22	2018-12-19	Biogen MA Inc.	Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
US8048420B2 (en)	2007-06-12	2011-11-01	Ac Immune S.A.	Monoclonal antibody
US8613923B2 (en)	2007-06-12	2013-12-24	Ac Immune S.A.	Monoclonal antibody
RU2482876C2 (ru)	2007-10-05	2013-05-27	Дженентек, Инк.	Применение антитела против амилоида-бета при глазных заболеваниях
BRPI1008692B8 (pt) *	2009-02-17	2021-05-25	Ucb Biopharma Sprl	anticorpo antagonista tendo especificidade para ox40 humano, sequência de dna isolado, vetor de clonagem ou de expressão, célula hospedeira, processo para a produção do referido anticorpo, composição farmacêutica, uso do 5 referido anticorpo e proteína de fusão
CN101531718B (zh) *	2009-04-22	2011-11-02	中国人民解放军南京军区军事医学研究所	抗VEGFR-2抗体嵌合Fab抗体片段及其制备方法、应用
SI2993231T1 (sl)	2009-09-24	2018-10-30	Ucb Biopharma Sprl	Bakterijski sev za izražanje rekombinantnega proteina, ki ima proteazno deficientno DEGP-zadrževalno šaperonsko aktivnost, ter onesposobljena gena TSP in PTR
GB201000590D0 (en)	2010-01-14	2010-03-03	Ucb Pharma Sa	Bacterial host strain
GB201000591D0 (en)	2010-01-14	2010-03-03	Ucb Pharma Sa	Bacterial hoist strain
GB201000587D0 (en)	2010-01-14	2010-03-03	Ucb Pharma Sa	Bacterial hoist strain
US8987419B2 (en)	2010-04-15	2015-03-24	AbbVie Deutschland GmbH & Co. KG	Amyloid-beta binding proteins
GB201012599D0 (en)	2010-07-27	2010-09-08	Ucb Pharma Sa	Process for purifying proteins
CN103179981B (zh)	2010-07-30	2017-02-08	Ac免疫有限公司	安全和功能性的人源化抗β‑淀粉样蛋白抗体
CN103298833B (zh)	2010-08-14	2015-12-16	Abbvie公司	β淀粉样蛋白结合蛋白
WO2013007388A1 (en)	2011-07-13	2013-01-17	Ucb Pharma, S.A.	Bacterial host strain expressing recombinant dsbc
CA2854153A1 (en)	2011-11-02	2013-05-10	Apexigen, Inc.	Anti-kdr antibodies and methods of use
UA112203C2 (uk)	2011-11-11	2016-08-10	Юсб Фарма С.А.	Злитий білок біоспецифічного антитіла, який зв'язується з ox40 людини та сироватковим альбуміном людини
CN104220458B (zh)	2012-02-24	2018-08-14	阿特根公司	结合有含半胱氨酸残基的基序的修饰抗体，含该修饰抗体的修饰抗体-药物缀合物以及其制造方法
GB201208367D0 (en)	2012-05-14	2012-06-27	Ucb Pharma Sa	Biological product
WO2014081202A1 (ko)	2012-11-21	2014-05-30	주식회사 파멥신	Vegfr-2와 dll4를 표적으로 하는 이중표적항체 및 이를 포함하는 약학적 조성물
EP3612625A4 (en)	2017-04-21	2021-08-18	Mellitus, LLC	PROCEDURE AND ANTIBODIES FOR DIABETES ASSOCIATED APPLICATIONS
EP3853377A4 (en)	2018-09-19	2022-10-05	Totient, Inc.	CANCER-ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE
JP2022514615A (ja) *	2018-12-20	2022-02-14	アルバートアインシュタインカレッジオブメディスン	ヒト免疫チェックポイントＣＥＡＣＡＭ１（ＣＤ６６ａ）に対するアンタゴニスト抗体及びその製剤、キット並びに使用方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
GB8719042D0 (en)	1987-08-12	1987-09-16	Parker D	Conjugate compounds
IL162181A (en)	1988-12-28	2006-04-10	Pdl Biopharma Inc	A method of producing humanized immunoglubulin, and polynucleotides encoding the same
GB8903022D0 (en)	1989-02-10	1989-03-30	Celltech Ltd	Chemical compounds
GB8928874D0 (en)	1989-12-21	1990-02-28	Celltech Ltd	Humanised antibodies
GB9014932D0 (en)	1990-07-05	1990-08-22	Celltech Ltd	Recombinant dna product and method
GB9112536D0 (en)	1991-06-11	1991-07-31	Celltech Ltd	Chemical compounds
GB9120467D0 (en)	1991-09-26	1991-11-06	Celltech Ltd	Anti-hmfg antibodies and process for their production
CN1701814A (zh)	1992-11-13	2005-11-30	马克斯普朗克科学促进协会	作为血管内皮生长因子受体的f1k－1
DE19638745C2 (de) *	1996-09-11	2001-05-10	Schering Ag	Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR)
US5980898A (en)	1996-11-14	1999-11-09	The United States Of America As Represented By The U.S. Army Medical Research & Material Command	Adjuvant for transcutaneous immunization
US6133426A (en) *	1997-02-21	2000-10-17	Genentech, Inc.	Humanized anti-IL-8 monoclonal antibodies
DE69838334T2 (de)	1997-06-18	2008-06-12	Merck & Co., Inc. (A New Jersey Corp.)	Kdr, ein menschlicher tyrosin kinase rezeptor
EP1086705A4 (en) *	1998-05-20	2002-02-06	Kyowa Hakko Kogyo Kk	INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ACTIVITY
GB9812545D0 (en)	1998-06-10	1998-08-05	Celltech Therapeutics Ltd	Biological products
EP1151002A4 (en) *	1999-01-29	2002-05-02	Imclone Systems Inc	KDR-SPECIFIC ANTIBODIES AND USES THEREOF

2001
- 2001-10-10 GB GBGB0124317.9A patent/GB0124317D0/en not_active Ceased
2002
- 2002-10-10 EP EP02800666A patent/EP1438340B1/en not_active Expired - Lifetime
- 2002-10-10 DK DK02800666.6T patent/DK1438340T3/da active
- 2002-10-10 KR KR1020047005051A patent/KR101018908B1/ko not_active Expired - Fee Related
- 2002-10-10 MX MXPA04003274A patent/MXPA04003274A/es active IP Right Grant
- 2002-10-10 HU HU0401618A patent/HUP0401618A3/hu unknown
- 2002-10-10 IL IL16084902A patent/IL160849A0/xx not_active IP Right Cessation
- 2002-10-10 BR BR0212756-3A patent/BR0212756A/pt not_active IP Right Cessation
- 2002-10-10 CN CNA028202104A patent/CN1568331A/zh active Pending
- 2002-10-10 KR KR1020077023689A patent/KR20070116110A/ko not_active Ceased
- 2002-10-10 ES ES02800666T patent/ES2351208T3/es not_active Expired - Lifetime
- 2002-10-10 AU AU2002334135A patent/AU2002334135B8/en not_active Ceased
- 2002-10-10 US US10/492,228 patent/US7452976B2/en not_active Expired - Fee Related
- 2002-10-10 NZ NZ532758A patent/NZ532758A/en not_active IP Right Cessation
- 2002-10-10 WO PCT/GB2002/004619 patent/WO2003031475A2/en not_active Ceased
- 2002-10-10 EA EA200400519A patent/EA010970B1/ru not_active IP Right Cessation
- 2002-10-10 AT AT02800666T patent/ATE482234T1/de not_active IP Right Cessation
- 2002-10-10 DE DE60237778T patent/DE60237778D1/de not_active Expired - Lifetime
- 2002-10-10 JP JP2003534457A patent/JP4323312B2/ja not_active Expired - Fee Related
- 2002-10-10 PL PL370344A patent/PL208848B1/pl not_active IP Right Cessation
- 2002-10-10 CA CA002458464A patent/CA2458464A1/en not_active Abandoned
2004
- 2004-03-05 IS IS7173A patent/IS7173A/is unknown
- 2004-03-08 NO NO20040987A patent/NO20040987L/no not_active Application Discontinuation
- 2004-03-09 ZA ZA200401910A patent/ZA200401910B/en unknown
- 2004-05-06 CO CO04041969A patent/CO5580838A2/es not_active Application Discontinuation
2007
- 2007-10-30 US US11/928,880 patent/US7842787B2/en not_active Expired - Fee Related
2008
- 2008-11-18 JP JP2008294819A patent/JP2009108086A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
US20050181448A1 (en)	2005-08-18
JP2005516590A (ja)	2005-06-09
WO2003031475A8 (en)	2004-10-14
EA010970B1 (ru)	2008-12-30
AU2002334135B2 (en)	2009-01-08
KR20040097983A (ko)	2004-11-18
EA200400519A1 (ru)	2004-12-30
CO5580838A2 (es)	2005-11-30
CN1568331A (zh)	2005-01-19
EP1438340A2 (en)	2004-07-21
MXPA04003274A (es)	2004-07-08
AU2002334135B8 (en)	2009-01-29
NZ532758A (en)	2008-04-30
PL208848B1 (pl)	2011-06-30
HUP0401618A3 (en)	2012-03-28
KR20070116110A (ko)	2007-12-06
US20090269840A1 (en)	2009-10-29
WO2003031475A2 (en)	2003-04-17
IL160849A0 (en)	2004-08-31
HUP0401618A2 (hu)	2004-11-29
US7452976B2 (en)	2008-11-18
ATE482234T1 (de)	2010-10-15
GB0124317D0 (en)	2001-11-28
CA2458464A1 (en)	2003-04-17
US7842787B2 (en)	2010-11-30
DK1438340T3 (da)	2010-11-22
ES2351208T3 (es)	2011-02-01
DE60237778D1 (de)	2010-11-04
JP4323312B2 (ja)	2009-09-02
BR0212756A (pt)	2004-11-16
WO2003031475A3 (en)	2004-03-25
EP1438340B1 (en)	2010-09-22
ZA200401910B (en)	2005-03-09
JP2009108086A (ja)	2009-05-21
PL370344A1 (en)	2005-05-16
KR101018908B1 (ko)	2011-03-02
IS7173A (is)	2004-03-05

Publication	Publication Date	Title
NO20040987L (no)	2004-05-10	Biologiske produkter
LTPA2017043I1 (lt)	2018-01-10	Antikūnai, specifiški žmogaus CD22, ir jų terapinis bei diagnostinis panaudojimas
MY136603A (en)	2008-10-31	Biological products
MXPA02011656A (es)	2004-07-30	Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
WO2002093519A3 (de)	2003-10-30	Humane hochaffine antikörperfragmente gegen essentielle proteine (ns3) von hepatitis-c-virus
MXPA03000980A (es)	2004-08-12	Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas.
WO2002088345A3 (en)	2003-08-28	Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene

Legal Events

Date	Code	Title	Description
2012-09-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application